Article Text

Download PDFPDF
Systematic review and meta-analysis
Cholinesterase inhibitors should not be prescribed for mild cognitive impairment
  1. Tom C Russ
  1. Division of Psychiatry, University of Edinburgh, Edinburgh, UK
  1. Correspondence to : Dr Tom C Russ, Division of Psychiatry, Kennedy Tower, Royal Edinburgh Hospital, University of Edinburgh, Morningside Terrace, Edinburgh EH10 5HF, UK; tom.russ{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text


Dementia is a chronic disease with insidious onset. Thus, Alzheimer disease can be present years, or even decades, before the clinical onset of Alzheimer dementia.1 ,2 Much research attention is being paid to biomarkers which, singly or in combination, may help identify which patients will go on to develop Alzheimer dementia while they are still asymptomatic, but their predictive validity is still inadequate.3 Many patients seen in clinical practice fall into the grey area of having some, relatively minor, memory problems which have little impact on their day-to-day functioning. These criteria are at the core …

View Full Text


  • Competing interests None.